Marksans Revenue At ₹531 Cr Up By 17.4% YoY In Q2FY24

Marksans Revenue At ₹531 Cr Up By 17.4% YoY In Q2FY24

The gross profit stood at Rs. 278.5 cr., reflecting a remarkable YoY surge of 21.4%, accompanied by a strong gross margin of 52.4%. EBITDA demonstrated substantial growth, reaching Rs. 113.9 cr., representing a remarkable 41.9% increase, with an EBITDA margin of 21.4%.

FPJ Web DeskUpdated: Thursday, November 09, 2023, 04:23 PM IST
article-image
Marksans Revenue At ₹531 Cr Up By 17.4% YoY In Q2FY24 |

Marksans Pharma Ltd. (NSE: MARKSANS; BSE Code: 524404) reported the financial results today for the quarter and half year ending September 30, 2023, the company announced through an exchange filing.

Q2FY24 Financial Highlights

The company reported robust financial performance, with operating revenue reaching Rs. 531.2 cr., marking a significant YoY increase of 17.4%. This growth was attributed to market share gains in existing products and markets.

The gross profit stood at Rs. 278.5 cr., reflecting a remarkable YoY surge of 21.4%, accompanied by a strong gross margin of 52.4%. EBITDA demonstrated substantial growth, reaching Rs. 113.9 cr., representing a remarkable 41.9% increase, with an EBITDA margin of 21.4%.

The company's earnings per share (EPS) also displayed positive momentum, growing by 21.2% YoY to Rs. 1.8.

H1FY24 Financial Highlights

In the fiscal year 2024, the company showcased strong financial performance, with operating revenue surging to Rs. 1,031.3 cr., marking an impressive YoY growth of 16.3%. This notable increase was fueled by the successful launch of new products and the acquisition of additional market share with existing customers, both domestically and internationally.

Specifically, the US business experienced a commendable growth of +14.1% YoY, while the UK and Europe regions saw an even more substantial growth of +22.6% YoY. The gross profit reached Rs. 535.8 cr., demonstrating a significant YoY increase of +19.5%, accompanied by a robust gross margin of 52.0%. EBITDA exhibited substantial growth, reaching Rs. 215.9 cr., reflecting an impressive 41.0% increase, with an EBITDA margin of 20.9%. Furthermore, the earnings per share (EPS) showed positive momentum, growing by 12.3% YoY to Rs. 3.4.

RECENT STORIES

Infrastructure Development Is Driving Property Sales In Mumbai; Here's How

Infrastructure Development Is Driving Property Sales In Mumbai; Here's How

How To Compare The Pros And Cons Of Under Construction And Ready Possession Residential Projects

How To Compare The Pros And Cons Of Under Construction And Ready Possession Residential Projects

Home Utsav: Property 2024 - Thane Beckoned Home Seekers To Fulfil Their Dreams

Home Utsav: Property 2024 - Thane Beckoned Home Seekers To Fulfil Their Dreams

How Does The Interim Budget Impact You?

How Does The Interim Budget Impact You?

Nvidia Spikes To $2 Trillion Market Cap As FOMO Drives Traders Into Stock: The Journey To Tech...

Nvidia Spikes To $2 Trillion Market Cap As FOMO Drives Traders Into Stock: The Journey To Tech...